{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:25:56Z","timestamp":1793057156096,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M743729"],"award-info":[{"award-number":["2023M743729"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M723344"],"award-info":[{"award-number":["2022M723344"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Air Force Special Medical Center Science and Technology Booster Program"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222040"],"award-info":[{"award-number":["82222040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170004"],"award-info":[{"award-number":["82170004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2020092"],"award-info":[{"award-number":["2020092"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAS Project for Young Scientists in Basic Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There have been reports of long coronavirus disease (long COVID) and breakthrough infections (BTIs); however, the mechanisms and pathological features of long COVID after Omicron BTIs remain unclear. Assessing long-term effects of COVID-19 and immune recovery after Omicron BTIs is crucial for understanding the disease and managing new-generation vaccines. Here, we followed up mild BA.2 BTI convalescents for six-month with routine blood tests, proteomic analysis and single-cell RNA sequencing (scRNA-seq). We found that major organs exhibited ephemeral dysfunction and recovered to normal in approximately six-month after BA.2 BTI. We also observed durable and potent levels of neutralizing antibodies against major circulating sub-variants, indicating that hybrid humoral immunity stays active. However, platelets may take longer to recover based on proteomic analyses, which also shows coagulation disorder and an imbalance between anti-pathogen immunity and metabolism six-month after BA.2 BTI. The immunity-metabolism imbalance was then confirmed with retrospective analysis of abnormal levels of hormones, low blood glucose level and coagulation profile. The long-term malfunctional coagulation and imbalance in the material metabolism and immunity may contribute to the development of long COVID and act as useful indicator for assessing recovery and the long-term impacts after Omicron sub-variant BTIs.<\/jats:p>","DOI":"10.1038\/s41467-024-46692-z","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T02:50:29Z","timestamp":1710816629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study"],"prefix":"10.1038","volume":"15","author":[{"given":"Yanhua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitong","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongshan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouzhen","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2001-1343","authenticated-orcid":false,"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-615X","authenticated-orcid":false,"given":"George Fu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"46692_CR1","unstructured":"Timeline: WHO\u2019s COVID-19 response. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/interactive-timeline (2022)."},{"key":"46692_CR2","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jmv.27515","volume":"94","author":"M Kandeel","year":"2022","unstructured":"Kandeel, M., Mohamed, M. E. M., Abd El-Lateef, H. M., Venugopala, K. N. & El-Beltagi, H. S. Omicron variant genome evolution and phylogenetics. J. Med. Virol. 94, 1627\u20131632 (2022).","journal-title":"J. Med. Virol."},{"key":"46692_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","volume":"7","author":"Y Fan","year":"2022","unstructured":"Fan, Y. et al. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct. Target Ther. 7, 141 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"46692_CR4","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jmv.27526","volume":"94","author":"S Kumar","year":"2022","unstructured":"Kumar, S., Thambiraja, T. S., Karuppanan, K. & Subramaniam, G. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J. Med. Virol. 94, 1641\u20131649 (2022).","journal-title":"J. Med. Virol."},{"key":"46692_CR5","unstructured":"COVID- 19 Clinical and Surveillance Data--Dec 9, 2022 to Jan 23, 2023, China. https:\/\/en.chinacdc.cn\/news\/latest\/202301\/t20230126_263523.html (2023)."},{"key":"46692_CR6","unstructured":"GISAID - NextStrain. https:\/\/gisaid.org\/phylodynamics\/global\/nextstrain\/ (2023)."},{"key":"46692_CR7","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","volume":"374","author":"H Crook","year":"2021","unstructured":"Crook, H., Raza, S., Nowell, J., Young, M. & Edison, P. Long covid-mechanisms, risk factors, and management. BMJ 374, n1648 (2021).","journal-title":"BMJ"},{"key":"46692_CR8","unstructured":"CDC. Long COVID or Post-COVID Conditions. Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects\/index.html (2023)."},{"key":"46692_CR9","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai, T. et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA 329, 1934\u20131946 (2023).","journal-title":"JAMA"},{"key":"46692_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijid.2021.12.357","volume":"116","author":"F Abdullah","year":"2022","unstructured":"Abdullah, F. et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa. Int. J. Infect. Dis. 116, 38\u201342 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"46692_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33614-0","volume":"13","author":"N Wolter","year":"2022","unstructured":"Wolter, N. et al. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat. Commun. 13, 5860 (2022).","journal-title":"Nat. Commun."},{"key":"46692_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399, 437\u2013446 (2022).","journal-title":"Lancet"},{"key":"46692_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2220578","volume":"12","author":"J Cai","year":"2023","unstructured":"Cai, J. et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg. Microbes Infect. 12, 2220578 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"46692_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade2283","volume":"7","author":"A Muik","year":"2022","unstructured":"Muik, A. et al. Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4\/BA.5. Sci. Immunol. 7, eade2283 (2022).","journal-title":"Sci. Immunol."},{"key":"46692_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","volume":"28","author":"Z Al-Aly","year":"2022","unstructured":"Al-Aly, Z., Bowe, B. & Xie, Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28, 1461\u20131467 (2022).","journal-title":"Nat. Med."},{"key":"46692_CR16","doi-asserted-by":"crossref","unstructured":"Morgan, P. China\u2019s COVID-19 Vaccine Supplies to the Global South: Between Politics and Business (Policy Press, 2022).","DOI":"10.1332\/policypress\/9781529226324.001.0001"},{"key":"46692_CR17","doi-asserted-by":"publisher","unstructured":"Government orders 4.3 million further doses of COVID-19 antivirals. Pharm. J. https:\/\/doi.org\/10.1211\/pj.2021.1.121425 (2021).","DOI":"10.1211\/pj.2021.1.121425"},{"key":"46692_CR18","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","volume":"395","author":"F-C Zhu","year":"2020","unstructured":"Zhu, F.-C. et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 395, 1845\u20131854 (2020).","journal-title":"Lancet"},{"key":"46692_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","volume":"10","author":"J-X Li","year":"2022","unstructured":"Li, J.-X. et al. Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial. Lancet Respir. Med 10, 739\u2013748 (2022).","journal-title":"Lancet Respir. Med"},{"key":"46692_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.7150\/ijbs.58791","volume":"17","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury. Int. J. Biol. Sci. 17, 1497\u20131506 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"46692_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/ATVBAHA.116.308198","volume":"37","author":"RM Kratofil","year":"2017","unstructured":"Kratofil, R. M., Kubes, P. & Deniset, J. F. Monocyte Conversion During Inflammation and Injury. Arterioscler. Thromb. Vasc. Biol. 37, 35\u201342 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"46692_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2014.05.010","volume":"291","author":"AJ Mitchell","year":"2014","unstructured":"Mitchell, A. J., Roediger, B. & Weninger, W. Monocyte homeostasis and the plasticity of inflammatory monocytes. Cell. Immunol. 291, 22\u201331 (2014).","journal-title":"Cell. Immunol."},{"key":"46692_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23494-1","volume":"12","author":"C Gutmann","year":"2021","unstructured":"Gutmann, C. et al. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care. Nat. Commun. 12, 3406 (2021).","journal-title":"Nat. Commun."},{"key":"46692_CR24","doi-asserted-by":"publisher","first-page":"e148635","DOI":"10.1172\/JCI148635","volume":"131","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes. J. Clin. Invest. 131, e148635 (2021).","journal-title":"J. Clin. Invest."},{"key":"46692_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","volume":"26","author":"M Reyes","year":"2020","unstructured":"Reyes, M. et al. An immune-cell signature of bacterial sepsis. Nat. Med. 26, 333\u2013340 (2020).","journal-title":"Nat. Med."},{"key":"46692_CR26","doi-asserted-by":"publisher","first-page":"eabe9599","DOI":"10.1126\/scitranslmed.abe9599","volume":"13","author":"M Reyes","year":"2021","unstructured":"Reyes, M. et al. Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro. Sci. Transl. Med. 13, eabe9599 (2021).","journal-title":"Sci. Transl. Med."},{"key":"46692_CR27","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00125-018-4733-9","volume":"61","author":"J Li","year":"2018","unstructured":"Li, J. et al. Circulating prolactin concentrations and risk of type 2 diabetes in US women. Diabetologia 61, 2549\u20132560 (2018).","journal-title":"Diabetologia"},{"key":"46692_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fimmu.2018.00073","volume":"9","author":"VV Borba","year":"2018","unstructured":"Borba, V. V., Zandman-Goddard, G. & Shoenfeld, Y. Prolactin and Autoimmunity. Front. Immunol. 9, 73 (2018).","journal-title":"Front. Immunol."},{"key":"46692_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0663-y","volume":"13","author":"T Dong","year":"2016","unstructured":"Dong, T., Zhi, L., Bhayana, B. & Wu, M. X. Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury. J. Neuroinflammation 13, 197 (2016).","journal-title":"J. Neuroinflammation"},{"key":"46692_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88957-3","volume":"11","author":"C Das","year":"2021","unstructured":"Das, C., Rout, M. K., Wildering, W. C. & Vijayan, M. M. Cortisol modulates calcium release-activated calcium channel gating in fish hepatocytes. Sci. Rep. 11, 9621 (2021).","journal-title":"Sci. Rep."},{"key":"46692_CR31","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1210\/jc.2005-0354","volume":"90","author":"IE Widmer","year":"2005","unstructured":"Widmer, I. E. et al. Cortisol Response in Relation to the Severity of Stress and Illness. J. Clin. Endocrinol. Metab. 90, 4579\u20134586 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"46692_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2215-0366(20)30141-3","volume":"7","author":"W Kawohl","year":"2020","unstructured":"Kawohl, W. & Nordt, C. COVID-19, unemployment, and suicide. Lancet Psychiatry 7, 389\u2013390 (2020).","journal-title":"Lancet Psychiatry"},{"key":"46692_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jad.2020.08.001","volume":"277","author":"J Xiong","year":"2020","unstructured":"Xiong, J. et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J. Affect. Disord. 277, 55\u201364 (2020).","journal-title":"J. Affect. Disord."},{"key":"46692_CR34","doi-asserted-by":"publisher","unstructured":"Klein, J. et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv, https:\/\/doi.org\/10.1101\/2022.08.09.22278592 (2022).","DOI":"10.1101\/2022.08.09.22278592"},{"key":"46692_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/0885066621997039","volume":"36","author":"A Chandel","year":"2021","unstructured":"Chandel, A. et al. Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation. J. Intensive Care Med. 36, 689\u2013695 (2021).","journal-title":"J. Intensive Care Med."},{"key":"46692_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/SHK.0000000000001660","volume":"55","author":"MA Mazzeffi","year":"2021","unstructured":"Mazzeffi, M. A., Chow, J. H. & Tanaka, K. COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management. Shock 55, 465\u2013471 (2021).","journal-title":"Shock"},{"key":"46692_CR37","doi-asserted-by":"publisher","first-page":"107602962096285","DOI":"10.1177\/1076029620962853","volume":"26","author":"A Kichloo","year":"2020","unstructured":"Kichloo, A. et al. COVID-19 and Hypercoagulability: A Review. Clin. Appl. Thromb. Hemost. 26, 1076029620962853 (2020).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"46692_CR38","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM199908193410807","volume":"341","author":"M Levi","year":"1999","unstructured":"Levi, M. & Ten Cate, H. Disseminated intravascular coagulation. N. Engl. J. Med. 341, 586\u2013592 (1999).","journal-title":"N. Engl. J. Med."},{"key":"46692_CR39","doi-asserted-by":"publisher","first-page":"103268","DOI":"10.1016\/j.msard.2021.103268","volume":"55","author":"J Lechner-Scott","year":"2021","unstructured":"Lechner-Scott, J., Levy, M., Hawkes, C., Yeh, A. & Giovannoni, G. Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 55, 103268 (2021).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"46692_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133\u2013146 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"46692_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1113\/EP090802","volume":"108","author":"R Astin","year":"2023","unstructured":"Astin, R. et al. Long COVID: mechanisms, risk factors and recovery. Exp. Physiol. 108, 12\u201327 (2023).","journal-title":"Exp. Physiol."},{"key":"46692_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19706-9","volume":"11","author":"W Tian","year":"2020","unstructured":"Tian, W. et al. Immune suppression in the early stage of COVID-19 disease. Nat. Commun. 11, 5859 (2020).","journal-title":"Nat. Commun."},{"key":"46692_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","volume":"23","author":"S Mehandru","year":"2022","unstructured":"Mehandru, S. & Merad, M. Pathological sequelae of long-haul COVID. Nat. Immunol. 23, 194\u2013202 (2022).","journal-title":"Nat. Immunol."},{"key":"46692_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","volume":"594","author":"Z Al-Aly","year":"2021","unstructured":"Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259\u2013264 (2021).","journal-title":"Nature"},{"key":"46692_CR45","first-page":"163","volume":"36","author":"P Suryawanshi","year":"2023","unstructured":"Suryawanshi, P. et al. Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India. Viral Immunol. 36, 163\u2013175 (2023).","journal-title":"Viral Immunol."},{"key":"46692_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12185-020-03029-y","volume":"113","author":"H Asakura","year":"2021","unstructured":"Asakura, H. & Ogawa, H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int. J. Hematol. 113, 45\u201357 (2021).","journal-title":"Int. J. Hematol."},{"key":"46692_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41421-022-00472-5","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Neutralization of Omicron BA.4\/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera. Cell Discov. 8, 110 (2022).","journal-title":"Cell Discov."},{"key":"46692_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq2427","volume":"7","author":"J Quandt","year":"2022","unstructured":"Quandt, J. et al. Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes. Sci. Immunol. 7, eabq2427 (2022).","journal-title":"Sci. Immunol."},{"key":"46692_CR49","doi-asserted-by":"publisher","first-page":"eabn8057","DOI":"10.1126\/scitranslmed.abn8057","volume":"14","author":"JP Evans","year":"2022","unstructured":"Evans, J. P. et al. Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection. Sci. Transl. Med. 14, eabn8057 (2022).","journal-title":"Sci. Transl. Med."},{"key":"46692_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJMc2206576","volume":"387","author":"NP Hachmann","year":"2022","unstructured":"Hachmann, N. P. et al. Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5. N. Engl. J. Med. 387, 86\u201388 (2022).","journal-title":"N. Engl. J. Med."},{"key":"46692_CR51","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1056\/NEJMc2206725","volume":"386","author":"P Qu","year":"2022","unstructured":"Qu, P. et al. Neutralization of the SARS-CoV-2 Omicron BA.4\/5 and BA.2.12.1 Subvariants. N. Engl. J. Med. 386, 2526\u20132528 (2022).","journal-title":"N. Engl. J. Med."},{"key":"46692_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.chom.2022.11.012","volume":"31","author":"P Qu","year":"2023","unstructured":"Qu, P. et al. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host Microbe 31, 9\u201317.e3 (2023).","journal-title":"Cell Host Microbe"},{"key":"46692_CR53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","volume":"182","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients\u2019 B Cells. Cell 182, 73\u201384.e16 (2020).","journal-title":"Cell"},{"key":"46692_CR54","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","volume":"184","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell 184, 1895\u20131913.e19 (2021).","journal-title":"Cell"},{"key":"46692_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"TM Delorey","year":"2021","unstructured":"Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107\u2013113 (2021).","journal-title":"Nature"},{"key":"46692_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/life12010057","volume":"12","author":"J Wei","year":"2022","unstructured":"Wei, J. & Hui, A. Review of Ribosome Interactions with SARS-CoV-2 and COVID-19 mRNA Vaccine. Life 12, 57 (2022).","journal-title":"Life"},{"key":"46692_CR57","doi-asserted-by":"publisher","first-page":"924667","DOI":"10.3389\/fimmu.2022.924667","volume":"13","author":"J Yuan","year":"2022","unstructured":"Yuan, J. et al. 3\u2019UTR of SARS-CoV-2 spike gene hijack host miR-296 or miR-520h to disturb cell proliferation and cytokine signaling. Front. Immunol. 13, 924667 (2022).","journal-title":"Front. Immunol."},{"key":"46692_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1056\/NEJMc2206900","volume":"387","author":"X Zhao","year":"2022","unstructured":"Zhao, X. et al. Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines. N. Engl. J. Med. 387, 277\u2013280 (2022).","journal-title":"N. Engl. J. Med."},{"key":"46692_CR59","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1056\/NEJMc2119426","volume":"386","author":"X Zhao","year":"2022","unstructured":"Zhao, X. et al. Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant. N. Engl. J. Med. 386, 894\u2013896 (2022).","journal-title":"N. Engl. J. Med."},{"key":"46692_CR60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.actbio.2022.04.026","volume":"145","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Synergistic effects of mechanical stimulation and crimped topography to stimulate natural collagen development for tendon engineering. Acta Biomater. 145, 297\u2013315 (2022).","journal-title":"Acta Biomater."},{"key":"46692_CR61","doi-asserted-by":"publisher","first-page":"983501","DOI":"10.3389\/fimmu.2022.983501","volume":"13","author":"Q Feng","year":"2022","unstructured":"Feng, Q. et al. The anti-aging effects of Renshen Guben on thyrotoxicosis mice: Improving immunosenescence, hypoproteinemia, lipotoxicity, and intestinal flora. Front. Immunol. 13, 983501 (2022).","journal-title":"Front. Immunol."},{"key":"46692_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","volume":"40","author":"E Dann","year":"2022","unstructured":"Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D. & Marioni, J. C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 40, 245\u2013253 (2022).","journal-title":"Nat. Biotechnol."},{"key":"46692_CR63","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types. Genomics Proteom. Bioinforma. 19, 578\u2013583 (2021).","journal-title":"Genomics Proteom. Bioinforma."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46692-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T03:03:42Z","timestamp":1710817422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46692-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["46692"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-46692-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"28 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2444"}}